336 Companies

Access all companies

Find technology partners quickly.

Spotfolio tracks over one million companies in technology industries.

There are 336 companies in the field of Biopharma on spotfolio that produce or deliver products, that utilize or research technologies or that are otherwise engaged in topics such as Clinical, Drug, Patients, Therapeutic, Treatment, Clinical-Trials, Clinical-Development, Biopharmaceutical, Tolerability .

Start-ups (42)

Early-stage companies (93)

Established companies (189)

The majority of these companies is located in the following countries.

United States (193)

Canada (17)

France (14)

United Kingdom (14)

Example Companies

Find companies in your area

Sitka Biopharma

early-stage

Access

  • Technologies
  • Core data such as location, employees, revenues
  • Similar and peer companies
  • and more

Web Quotes

proprietary HPG nanoparticle platform technology to improve the efficacy and tolerability of established drugs. Our most advanced candidate, STK-01, is in late-stage

established drugs. Our lead program, STK-01, aims to improve efficacy and tolerability of treatment for non-muscle-invasive bladder cancer. Our technology

Theravectys

established

Access

  • Technologies
  • Core data such as location, employees, revenues
  • Similar and peer companies
  • and more

Web Quotes

Clinical Trials Infectious diseases HUMAN IMMUNODEFICIENCY VIRUS Safety, tolerability & immunogenicity vaccination study in HIV-1 positive patients A multi-center ...

double-blind, placebo-controlled Phase I/II trial to compare the safety, tolerability and immunogenicity of THV01, a therapeutic vaccine at 5.106, 5.107 and ...

communications. objectives - The primary objective is to compare the safety and tolerability of THV01 by treatment group and versus placebo from Week 0 to Week 24

Oncoscience Oncoscience GmbH

established

Access

  • Technologies
  • Core data such as location, employees, revenues
  • Similar and peer companies
  • and more

Web Quotes

recurrent patients (ASCO 2008) and serve to further confirm the excellent tolerability of Nimotuzumab compared to aggressive chemotherapy, absence of side-effects ...

recurrent patients (ASCO 2008) and serve to further confirm the excellent tolerability of Nimotuzumab compared to aggressive chemotherapy, as well as absence

AptaTargets

early-stage

Access

  • Technologies
  • Core data such as location, employees, revenues
  • Similar and peer companies
  • and more

Web Quotes

dose ascending, randomized, placebo-controlled clinical trial to assess tolerability and pharmacokinetics of ApTOLL in healthy volunteers. ApTOLL is a DNA ...

dose ascending, randomized, placebo-controlled clinical trial to assess tolerability and pharmacokinetics of ApTOLL in healthy volunteers. ApTOLL is a DNA ...

dose ascending, randomized, placebo-controlled clinical trial to assess tolerability and pharmacokinetics of ApTOLL in healthy volunteers. ApTOLL is a DNA ...

dose ascending, randomized, placebo-controlled clinical trial to assess tolerability and pharmacokinetics of ApTOLL in healthy volunteers. ApTOLL is a DNA ...

dose ascending, randomized, placebo-controlled clinical trial to assess tolerability and pharmacokinetics of ApTOLL in healthy volunteers. ApTOLL is a DNA

dose ascending, randomized, placebo-controlled clinical trial to assess tolerability and pharmacokinetics of ApTOLL in healthy volunteers. ApTOLL is a DNA ...

dose ascending, randomized, placebo-controlled clinical trial to assess tolerability and pharmacokinetics of ApTOLL in healthy volunteers. ApTOLL is a DNA ...

dose ascending, randomized, placebo-controlled clinical trial to assess tolerability and pharmacokinetics of ApTOLL in healthy volunteers. ApTOLL is a DNA

Edgewise Therapeutics Edgewise Therapeutics.

start-up

Access

  • Technologies
  • Core data such as location, employees, revenues
  • Similar and peer companies
  • and more

Web Quotes

trial of EDG-5506. The Phase 1 trial is designed to assess the safety, tolerability and pharmacokinetics (PK) of EDG-5506 in adult healthy volunteers and ...

and Multiple Ascending Dose (SAD and MAD) study evaluating the safety, tolerability, PK and pharmacodynamics of EDG-5506 in adult healthy volunteers and ...

study will enroll adult patients with BMD following appropriate safety, tolerability and PK results of EDG-5506 in healthy volunteers. To learn more about

information from CISCRP ┬╗ Active Clinical Trials A Study to Assess Safety, Tolerability, and PK of EDG-5506 in Healthy Volunteers and Becker Muscular Dystrophy ...

muscle fibers. This Phase 1 study of EDG-5506 will assess the safety, tolerability, and pharmacokinetics (PK) and of EDG-5506 in adult healthy volunteers

Use detailed technology terms.

Only spotfolio allows for searching with detailed technology terms, as we provide you with all topics that technology companies talk about.

Companies addressing these topics might be of specific interest to you, as they share more specific, niche topics.

Use Cases

Register now

Why Technology Scouting?

Technology scouting is the basis for your innovation management, identifies new technological developments as early as possible and protects you from disruptive business models.

Identify technology partners

Boost your market research

Look beyond major players

Build long and short lists

Collect technology leaders, providers, start ups and potential new partners in lists via simple tagging to take further steps with your team.